Pattern forming method and processing liquid for metal compound-containing film
The method employs a treatment liquid with specific solvent characteristics to form and pattern metal compound-containing films, overcoming absorption and etching resistance issues in EUV lithography, ensuring effective pattern formation and resistance in semiconductor manufacturing.
Patent Information
- Application Number
- PCT/JP2024/018746
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-24
- Filing Date
- 2024-05-21
- Publication Date
- 2024-11-28
AI Technical Summary
The challenge in semiconductor device manufacturing lies in forming patterns smaller than the wavelength of light used in photolithography, particularly with extreme ultraviolet (EUV) lithography, where chemically amplified organic resists face absorption issues and high aspect ratios lead to pattern collapse, necessitating a method for forming thin metal compound-containing films with excellent etching resistance.
A pattern forming method using a treatment liquid with an organic solvent containing solvents where ClogP≦0.7 and ΔH+ΔP≧16, with a content of 30% or more, and optionally including additional solvents and water, to selectively reduce unexposed areas of metal compound-containing films, enabling pattern formation and etching resistance even in thin films.
This method allows for effective pattern formation and etching resistance in metal compound-containing films, particularly suitable for polyoxometalate-containing films, using EUV or electron beam lithography, addressing the limitations of traditional resists and preventing pattern collapse.
Smart Images

Figure JPOXMLDOC01-APPB-C000001 
Figure JPOXMLDOC01-APPB-C000002 
Figure JPOXMLDOC01-APPB-C000003
Abstract
Description
Pattern forming method and treatment solution for metal compound-containing film
[0001] The present invention relates to a pattern forming method and a treatment liquid for a metal compound-containing film.
[0002] The evolution of semiconductor device design to meet the need for improved semiconductor device performance has been achieved by shrinking feature sizes on semiconductor substrates. The rate of this technological progress is explained by the so-called "Moore's Law," which states that the density of transistors in high-density integrated circuits doubles every two years. In fact, the design and manufacturing of semiconductor device chips has advanced to the point where billions of transistors and circuits are formed on a single chip.
[0003] The size of individual structures on semiconductor device chips is approximately 22 nm or less, and in some cases, less than 10 nm. The photolithography process for forming these microstructures typically uses ultraviolet (UV) light with a wavelength of 193 nm for exposure. However, this light wavelength is already significantly larger than the desired pattern size to be formed on the semiconductor substrate. This creates various problems. For example, achieving pattern sizes smaller than the wavelength of light requires complex high-resolution techniques such as multi-patterning. Therefore, the development of lithography technologies using ultrashort wavelength light, such as extreme ultraviolet (EUV) light with a wavelength of approximately 10 to 15 nm (e.g., 13.5 nm), or particle beams such as electron beams (EB) is extremely important.
[0004] However, in photolithography processes using EUV, it is difficult to apply chemically amplified organic resists due to the absorption characteristics of the resist composition. Furthermore, in order to impart sufficient etching resistance to a patterned resist film formed using an organic resist, the resist film must be made thick. In this case, the patterned resist film has a high aspect ratio, which poses a high risk of pattern collapse. Given these circumstances, there is a need for a method for forming a resist film that can be well patterned using EUV (extreme ultraviolet) or electron beam lithography and that exhibits excellent etching resistance even at thin films.
[0005] In response to such demands, metal compound-containing resists using tin compounds or the like have been proposed (for example, Patent Documents 1 and 2).
[0006] US Patent No. 1,392,028 US Patent Application Publication No. 2021 / 026241
[0007] The present invention has been made in view of the above-described conventional circumstances, and an object of the present invention is to provide a method for forming a pattern of a metal compound-containing film, and a treatment liquid that can be suitably used in forming a pattern of a metal compound-containing film.
[0008] As a result of intensive research to solve the above-mentioned problems, the present inventors have found that, after exposing a metal compound-containing film, the unexposed areas of the metal compound-containing film can be selectively reduced and a pattern can be formed by using a treatment liquid containing an organic solvent, where the organic solvent contains one or more first solvents that satisfy (1) ClogP≦0.7 and (2) ΔH+ΔP≧16, and the content of the first solvent is 30 mass % or more relative to 100 mass % of the organic solvent, and have thus completed the present invention.
[0009] That is, the present invention relates to the following inventions: [1] A pattern formation method comprising the steps of exposing a metal compound-containing film and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains an organic solvent, the organic solvent contains one or more first solvents that satisfy ClogP≦0.7 and ΔH+ΔP≧16, and the content of the first solvent is 30% by mass or more relative to 100% by mass of the organic solvent. [2] A pattern formation method comprising the steps of forming a metal compound-containing film using a metal compound-containing film-forming composition, exposing the metal compound-containing film, and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains an organic solvent, the organic solvent contains one or more first solvents that satisfy ClogP≦0.7 and ΔH+ΔP≧16, and the content of the first solvent is 30% by mass or more relative to 100% by mass of the organic solvent. [3] The pattern formation method according to [1], wherein the organic solvent further comprises one or more second solvents different from the first solvent, and the content of the second solvent is 1 to 70 mass % relative to 100 mass % of the organic solvent. [4] The pattern formation method according to [3], wherein the second solvent is different from the first solvent and is one or more organic solvents selected from the group consisting of alcohol solvents containing three or more carbon atoms, ester solvents containing three or less oxygen atoms, and ketone solvents containing two or fewer oxygen atoms. [5] The pattern formation method according to [3], wherein the second solvent is one or more solvents satisfying ClogP > 0.7 and ΔH + ΔP ≦ 25, or ClogP ≧ 0.35 and ΔH + ΔP < 16. [6] The pattern formation method according to [3], wherein the second solvent is one or more solvents selected from the group consisting of propylene glycol monomethyl ether acetate (PGMEA), ethyl acetate, butyl acetate, 3-methoxy-3-methyl-1-butanol, 4-methyl-2-pentanol (MIBC), methyl isobutyl ketone (MIBK), benzyl alcohol, t-butyl alcohol, octanol, hexane, decane, and diethylene glycol monobutyl ether (BDG).[7] The pattern formation method according to [1], wherein the treatment liquid further contains water. [8] The pattern formation method according to [7], wherein the content of the water is 1 to 75 mass % relative to 100 mass % of the treatment liquid. [9] The pattern formation method according to [1], wherein the metal compound-containing film is a metal compound-containing film containing a metal element of Groups 3 to 7.
[10] The pattern formation method according to [1], wherein the metal compound is a polyoxometalate.
[11] The pattern formation method according to
[10] , wherein the polyoxometalate is a polyoxomolybdate, polyoxotungstate, polyoxovanadate, polyoxoniobate, or polyoxotantalate.
[12] The pattern formation method according to
[10] , wherein the polyoxometalate is an onium salt.
[13] The pattern formation method according to
[12] , wherein the onium salt is an ammonium salt, a sulfonium salt, or an iodonium salt.
[14] The pattern formation method according to [1], wherein the exposing step is a step of exposing with EUV or an electron beam.
[15] A treatment solution for a metal compound-containing film, the treatment solution containing an organic solvent, the organic solvent containing one or more first solvents satisfying ClogP≦0.7 and ΔH+ΔP≧16, the content of the first solvent being 30% by mass or more relative to 100% by mass of the organic solvent.
[16] The treatment solution for a metal compound-containing film according to
[15] , the organic solvent further containing one or more second solvents different from the first solvent, the content of the second solvent being 1 to 70% by mass relative to 100% by mass of the organic solvent.
[17] The metal compound-containing film treatment solution according to
[16] , wherein the second solvent is different from the first solvent and is one or more organic solvents selected from the group consisting of alcohol-based solvents containing three or more carbon atoms, ester-based solvents containing three or less oxygen atoms, and ketone-based solvents containing two or less oxygen atoms.
[18] The metal compound-containing film treatment solution according to
[16] , wherein the second solvent is one or more solvents satisfying ClogP>0.7 and ΔH+ΔP≦25, or ClogP≧0.35 and ΔH+ΔP<16.
[19] The metal compound-containing film treatment solution according to
[16] , wherein the second solvent is one or more solvents selected from the group consisting of propylene glycol monomethyl ether acetate (PGMEA), ethyl acetate, butyl acetate, 3-methoxy-3-methyl-1-butanol, 4-methyl-2-pentanol (MIBC), methyl isobutyl ketone (MIBK), benzyl alcohol, t-butyl alcohol, octanol, hexane, decane, and diethylene glycol monobutyl ether (BDG).
[20] The metal compound-containing film treatment solution according to
[15] , wherein the treatment solution further contains water.
[21] The metal compound-containing film treatment solution according to any one of
[15] to
[20] , wherein the metal compound-containing film treatment solution is a polyoxometalate-containing film treatment solution.
[0010] The present invention provides a method for forming a pattern of a metal compound-containing film and a treatment liquid suitable for use in forming a pattern of a metal compound-containing film. Furthermore, the treatment liquid according to the present invention can selectively reduce the film thickness in unexposed areas of a metal compound-containing film, and is therefore suitable for use as a treatment liquid for metal compound films, particularly as a treatment liquid for polyoxometalate-containing films.
[0011] Preferred embodiments of the present invention will be described in detail below, but the present invention is not limited to the following embodiments.
[0012] [1. Pattern Forming Method] The pattern forming method according to this embodiment includes the steps of forming a metal compound-containing film on a substrate using a metal compound-containing film-forming composition, exposing the metal compound-containing film to light, and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains an organic solvent, and the organic solvent contains one or more first solvents that satisfy the following conditions (1) and (2), and the content of the first solvent is 30% by mass or more relative to 100% by mass of the organic solvent: (1) ClogP≦0.7 (2) ΔH+ΔP≧16
[0013] [1-1. Metal Compound-Containing Film-Forming Composition] The metal compound-containing film-forming composition according to this embodiment contains a metal compound. The metal compound is not particularly limited, and examples of the metal compound include metal atoms or metal ions of metal elements in Groups 3 to 16 of the long-form periodic table, metal oxides of the metal atoms or metal ions, and compounds containing bonds that bond to the metal atoms, metal ions, or metal oxides via ionic, coordinate, or covalent bonds.
[0014] [1-1-1. Metal Compound] <Metal Element> As the metal element contained in the metal compound, metal elements of Groups 3 to 16 of the long-form periodic table can be used. Examples of metal elements of Groups 3 to 16 of the long-form periodic table include metal elements of Group 3 such as scandium (Sc), yttrium (Y), lanthanum (La), and cerium (Ce); metal elements of Group 4 such as titanium (Ti), zirconium (Zr), and hafnium (Hf); metal elements of Group 5 such as vanadium (V), niobium (Nb), and tantalum (Ta); metal elements of Group 6 such as chromium (Cr), molybdenum (Mo), and tungsten (W); metal elements of Group 7 such as manganese (Mn) and rhenium (Re); metal elements of Group 8 such as iron (Fe), ruthenium (Ru), and osmium (Os); cobalt (Co), ruthenium (Ru), and ruthenium (Ru). Examples of metal elements include Group 9 metal elements such as rhenium (Rh) and iridium (Ir); Group 10 metal elements such as nickel (Ni), palladium (Pd), and platinum (Pt); Group 11 metal elements such as copper (Cu), silver (Ag), and gold (Au); Group 12 metal elements such as zinc (Zn), cadmium (Cd), and mercury (Hg); Group 13 metal elements such as aluminum (Al), gallium (Ga), indium (In), and thallium (Tl); Group 14 metal elements such as germanium (Ge), tin (Sn), and lead (Pb); Group 15 metal elements such as antimony (Sb) and bismuth (Bi); and Group 16 metal elements such as tellurium (Te). The metal compound may contain one of the above metal elements alone, or two or more of them may be combined.
[0015] Among the above metal elements, it is preferable to use metal elements from Groups 3 to 16 in the fourth to sixth periods as the metal element contained in the metal compound. While tin compounds and the like can be suitably used as the metal compound, problems may arise with tin compounds, such as contamination of equipment due to residues generated during coating processing and the toxicity of the tin compounds themselves. Therefore, among the above metal elements, it is more preferable to use metal elements from Groups 3 to 7 as the metal compound, and it is even more preferable to use metal elements from Groups 3 to 7 in the fourth to sixth periods.
[0016] <Metal Oxide> The metal oxide of the metal atom or metal ion of the above metal element is not particularly limited, and known and commonly used metal oxides can be used. Examples of the metal oxide include scandium oxide (Sc 2 O 3 ), yttrium oxide (Y 2 O 3 ), titanium oxide (TiO 2 ), zirconium oxide (ZrO 2 ), hafnium oxide (HfO 2 ), vanadium oxide (V 2 O 5 ), niobium oxide (Nb 2 O 5 ), tantalum oxide (Ta 2 O 5 ), chromium oxide (CrO 3 ), molybdenum oxide (MoO 3 ), tungsten oxide (WO 3 ), aluminum oxide (Al 2 O 3 ), gallium oxide (Ga 2 O 3 ), indium oxide (In 2 O 3 ), germanium dioxide (GaO 2 ), tin oxide (SnO), antimony trioxide (Sb 2 O 3 ) etc. can be used.
[0017] (Polyoxometalate) As the metal oxide, polyoxometalate (polyacid salt) can be suitably used. x O y ] n- (wherein x, y, and n are all natural numbers). The metal atom M constituting the polyoxometalate is called a polyatom, and examples thereof include Mo (hexavalent or pentavalent), W (hexavalent or pentavalent), V (pentavalent), Nb (pentavalent), and Ta (pentavalent). Polyoxometalates include isopolyoxometalates composed of the polyatom M and an oxyacid, and polyoxometalates containing different types of atoms X (for example, heteroatoms X such as P 5+ , Si 4+ , Ge 4+ , B 3+ Heteropolyoxometalates ([X w M x O y ] n- (wherein w, x, y, and n are all natural numbers)
[0018] Examples of isopolyoxometalates include salts of isopolyoxomolybdic acid, isopolyoxotungstic acid, isopolyoxovanadic acid, isopolyoxoniobic acid, and isopolyoxotantalic acid. Examples of the isopolyoxomolybdic acid include, for example, [MoO 4 ] 2- , [Mo 7 O 24 ] 6- , [Mo 8 O 26 ] 4- Examples of the isopolyoxotungstic acid include [W 4 O 13 ] 2- , [W 5 O 16 ] 2- , [W 6 O 19 ] 2- , [W 7 O 22 ] 2- , [W7 O 24 ] 6- , [H z W 12 O 40 ] -(8-z) (wherein z represents an integer of 1 to 4), [W 10 O 32 ] 4- , [H 4 W 11 O 38 ] 6- , [H 7 W 11 O 40 ] 7- , [HW 5 O 19 ] 7- , [H 3 W 11 O 22 ] 5- Examples of the isopolyoxovanadic acid include [V 4 O 12 ] 4- , [V 10 O 28 ] 6- The isopolyoxoniobic acid may, for example, be [Nb 6 O 19 ] 8- , [Nb 10 O 28 ] 6- Examples of the isopolyoxotantalic acid include [Ta 6 O 19 ] 8- , [Ta 8 O 21 ] 2- The above-mentioned isopolyoxomolybdic acid, isopolyoxotungstic acid, isopolyoxovanadic acid, isopolyoxoniobic acid, and isopolyoxotantalic acid include various isomers.
[0019] Examples of heteropolyoxometalates include salts of heteropolyoxomolybdic acid, heteropolyoxotungstic acid, heteropolyoxovanadic acid, heteropolyoxoniobic acid, and heteropolyoxotantalic acid. Examples of heteropolyoxomolybdic acids include phosphomolybdic acid, silicomolybdic acid, boromolybdic acid, phosphotungstomolybdic acid, cobaltomolybdic acid, arsenic molybdic acid, and germanomolybdic acid. Examples of heteropolyoxotungstic acids include phosphotungstic acid, silicotungstic acid, borotungstic acid, cobaltotungstic acid, arsenic tungstic acid, and germanotungstic acid. Examples of the heteropolyoxovanadic acid include phosphomolybdovanadic acid, phosphomolybdotungstomolybdic acid, boromolybdovanadic acid, boromolybdotungstovanadic acid, etc. The heteropolyoxomolybdic acid, heteropolyoxotungstic acid, heteropolyoxovanadic acid, etc. include Keggin type, Dawson type, Anderson type, and defect species and isomers thereof.
[0020] The type of salt of a polyacid salt (isopolyoxometalate or heteropolyoxometalate) is not particularly limited, and may be a salt with a proton, an onium cation (e.g., an organic onium cation, an organic sulfonium cation, an organic iodonium cation, an organic quaternary ammonium cation, an organic phosphonium cation, etc.), an alkali metal ion, etc. From the viewpoint of improving actinic ray sensitivity or radiation sensitivity and varying the solvent solubility of exposed and unexposed areas, the type of salt of a polyacid salt is preferably a salt with an onium cation, and among these, a salt with an organic sulfonium cation, an organic iodonium cation, or an organic quaternary ammonium cation is more preferred.
[0021] The organic sulfonium cation is not particularly limited, and any known and commonly used organic sulfonium cation can be used. Examples of the organic sulfonium cation include organic sulfonium cations represented by formula (I):
[0022]
[0023] In formula (I), R 1A , R 1B and R 1C are each independently C 1-18 represents a hydrocarbyl group, a 3- to 18-membered non-aromatic heterocyclic group, or a 5- to 18-membered aromatic heterocyclic group, 1A , R 1B and R 1C The divalent carbon atom at any position excluding the terminal may be -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S- or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 1A , R 1B and R 1C The hydrogen atoms contained in the formula (I) are, for example, (a) halogen atoms, (b) haloalkyl groups, (c) hydroxy groups, (d) thiol groups, (e) nitro groups, (f) cyano groups, (g) carboxy groups, (h) amino groups, (i) sulfo groups, (j) hydroxy groups or carboxy groups having a protecting group, or (k) C groups in which at least a part of the hydrogen atoms may be substituted with the above (a) to (j). 1-18 Hydrocarbyl group, C 1-18 Hydrocarbyloxy group, C 1-18 Hydrocarbyl carbonyl group, C 1-18 Hydrocarbylcarbonyloxy group, C 1-18 Hydrocarbyloxycarbonyl group, C 1-18 a hydrocarbyloxycarbonyloxy group, or C 1-18 In a hydrocarbylthio group, the divalent carbon atom at any position except at the terminal of these substituents is -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S-, or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 1A , R 1B and R 1CAny two of these are directly connected to each other by a single bond, or are divalent linking groups -O-, -S-, -C(=O)-, -S(=O)-, -S(=O) 2 -, -C(=O)O-, or C 1-3 They may be linked via an alkylene group to form a ring together with the sulfur atom in formula (I).
[0024] In this specification, the term "hydroxy group or carboxy group having a protecting group" refers to a hydroxy group (including a phenolic hydroxyl group) or a carboxy group protected by an ether-based protecting group, a silyl ether-based protecting group, an acyl-based protecting group, an aminocarbonyl-based protecting group, or the like. The ether-based protecting group is not particularly limited, and examples thereof include a methyl group, a benzyl group, a p-methoxybenzyl group, a t-butyl group, a triphenylmethyl group, a p-methoxyphenyldiphenylmethyl group, and a di(p-methoxyphenyl)phenylmethyl group. The silyl ether-based protecting group is not particularly limited, and examples thereof include a t-butyldimethylsilyl group (TBS), a triisopropylsilyl group (TIPS), a trimethylsilyl group (TMS), a triethylsilyl group (TES), and a t-butyldiphenylsilyl group (TBDPS). The acyl-based protecting group is not particularly limited, and examples thereof include an acetyl group, a pivaloyl group, and a benzoyl group. The aminocarbonyl protecting group is not particularly limited, and examples thereof include a dimethylaminocarbonyl group, a diethylaminocarbonyl group, a diisopropylaminocarbonyl group, and an N-phenyl-N-methyl-aminocarbonyl group.
[0025] R in formula (I) 1A , R 1B and R 1C Each of the C groups independently has a substituent. 6-18 It is preferably an aryl group. 6-18 The substituent of the aryl group may be a halogen atom, a haloalkyl group, a hydroxy group, a nitro group, a cyano group, a C 1-12 A hydrocarbylthio group is preferred, a halogen atom, C 1-4A haloalkyl group or a nitro group is more preferred.
[0026] Specific examples of the organic sulfonium cation include dibutyl(pentyl)sulfonium cation, triethylsulfonium cation, (2-carboxyethyl)dimethylsulfonium cation, trimethylsulfonium cation, dimethylphenacylsulfonium cation, 1-(4-hydroxynaphthalen-1-yl)hexahydrothiopyrylium cation, dimethylphenylsulfonium cation, triphenylsulfonium cation, tris(4-methylphenyl)sulfonium cation, 4-methoxyphenyldiphenylsulfonium cation, 4-iodophenyldiphenylsulfonium cation, tris(4-fluorophenyl)sulfonium cation, 1-phenylhexahydrothiopyrylium cation, (ethane-1,2-diylbisoxy)bis(4,1-phenylene)bis(diphenylsulfonium) dication, (thiodi-4,1-phenylene)bis(diphenylsulfonium) dication, di(naphthalen-1-yl)(fluorophenyl)sulfonium cation, and di(naphthalen-1-yl)(fluorophenyl)sulfonium cation. phenyl)sulfonium cation, phenylbis(2-(trifluoromethyl)phenyl)sulfonium cation, mesitylbis(2-(trifluoromethyl)phenyl)sulfonium cation, bis(3,5-difluorophenyl)(phenyl)sulfonium cation, tris(3,5-difluorophenyl)sulfonium cation, (4-(dodecanoyloxy-3,5-dimethylphenyl))diphenylsulfonium cation, diphenyl(3-(trifluoromethoxy)phenyl)sulfonium cation, (4-(1-adamantylcarbonyloxy)phenyl)diphenylsulfonium cation, (4-phenylthiophenyl)diphenylsulfonium cation, 5-phenyl-5H-thianthren-5-ium cation, 5-(2,5-dimethylphenyl)thianthren-5-ium cation, 5-phenyl-5H-dibenzo[b,d]thiophen-5-ium cation 5-(3-(trifluoromethyl)phenyl)-5H-dibenzo[b,Examples of the thiophene-5-ium cation include 1-(4-(t-butyl)phenyl)-1H-benzo[b]thiophen-1-ium cation, methyldiphenylsulfonium cation, (2-bromoethyl)diphenylsulfonium cation, (3-chloropropyl)diphenylsulfonium cation, benzyl(4-hydroxyphenyl)methylsulfonium cation, (4-hydroxyphenyl)methyl(2-methylbenzyl)sulfonium cation, 4-hydroxyphenyldimethylsulfonium cation, diphenyl(methyl)sulfonium cation, diphenyl(4-(phenylthio)phenyl)sulfonium cation, (2-bromoethyl)diphenylsulfonium cation, dimesityl(trifluoromethyl)sulfonium cation, and tri-p-tolyl sulfonium cation.
[0027] The organic iodonium cation is not particularly limited, and any known and commonly used organic iodonium cation can be used. Examples of the organic iodonium cation include organic iodonium cations represented by formula (II):
[0028]
[0029] In formula (II), R 2A and R 2B are each independently C 1-18 represents a hydrocarbyl group, a 3- to 18-membered non-aromatic heterocyclic group, or a 5- to 18-membered aromatic heterocyclic group, 2A and R 2B The divalent carbon atom at any position excluding the terminal may be -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S- or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 2A and R 2BThe hydrogen atoms contained in the formula (I) are, for example, (a) halogen atoms, (b) haloalkyl groups, (c) hydroxy groups, (d) thiol groups, (e) nitro groups, (f) cyano groups, (g) carboxy groups, (h) amino groups, (i) sulfo groups, (j) hydroxy groups or carboxy groups having a protecting group, or (k) C groups in which at least a part of the hydrogen atoms may be substituted with the above (a) to (j). 1-18 Hydrocarbyl group, C 1-18 Hydrocarbyloxy group, C 1-18 Hydrocarbyl carbonyl group, C 1-18 Hydrocarbylcarbonyloxy group, C 1-18 a hydrocarbyloxycarbonyl group, or C 1-18 A hydrocarbyloxycarbonyloxy group in which a divalent carbon atom at any position except the terminal of these substituents is -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S-, or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 2A and R 2B are directly connected to each other by a single bond, or are connected to each other by a divalent linking group, -O-, -S-, -C(=O)-, -S(=O)-, -S(=O) 2 -, -C(=O)O-, or C 1-3 They may be linked via an alkylene group to form a ring together with the iodine atom in formula (II).
[0030] R in formula (II) 2A and R 2B Each of the C groups independently has a substituent. 6-18 It is preferably an aryl group. 6-18 The substituent of the aryl group may be a halogen atom, a haloalkyl group, a hydroxy group, a nitro group, a cyano group, a C 1-12 Hydrocarbyl group, C 1-12 Hydrocarbyloxy group, C 1-12 Hydrocarbyl carbonyl group, C 1-12 Hydrocarbylcarbonyloxy group, C 1-12a hydrocarbyloxycarbonyl group, or C 1-12 A hydrocarbyloxycarbonyloxy group is preferred, and a halogen atom, C 1-4 Haloalkyl group, nitro group, C 1-8 Hydrocarbyl group, C 1-8 It is preferably a hydrocarbyloxy group.
[0031] Specific examples of the organic iodonium cation include ethynyl(phenyl)iodonium cation, bis(pyridine)iodonium cation, bis(2,4,6-trimethylpyridine)iodonium cation, diphenyliodonium cation, bis(4-(t-butyl)phenyl)iodonium cation, (2-carboxyphenyl)(phenyl)iodonium cation, (4-nitrophenyl)(phenyl)iodonium cation, (3-(trifluoromethyl)phenyl)(2,4,6-trimethylphenyl)iodonium cation, bis(4-fluorophenyl)iodonium cation, (4-(bromomethyl)phenyl)(2,4,6-trimethoxyphenyl)iodonium cation, 4-biphenylyl(2,4,6-trimethoxyphenyl)iodonium cation, bis(2,4,6-trimethylphenyl)iodonium cation, 4-isopropyl-4'-methyldiphenyliodonium cation, Examples of iodonium cation include (4-(trifluoromethyl)phenyl)(2,4,6-trimethylphenyl)iodonium cation, ((4-trifluoromethyl)phenyl)(2,4,6-trimethoxyphenyl)iodonium cation, (5-fluoro-2-nitrophenyl)(2,4,6-trimethoxyphenyl)iodonium cation, (3-bromophenyl)(mesityl)iodonium cation, bis(4-bromophenyl)iodonium cation, (3,5-dichlorophenyl)(2,4,6-trimethoxyphenyl)iodonium cation, (4-methylphenyl)(2,4,6-trimethylphenyl)iodonium cation, (3-methylphenyl)(2,4,6-trimethylphenyl)iodonium cation, (2-methylphenyl)(2,4,6-trimethylphenyl)iodonium cation, and phenyl(2,4,6-trimethoxyphenyl)iodonium cation.
[0032] The organic quaternary ammonium cation is not particularly limited, and any known or commonly used organic quaternary ammonium cation can be used. Examples of the organic quaternary ammonium cation include organic quaternary ammonium cations represented by formula (III):
[0033]
[0034] In formula (III), R 3A , R 3B , R 3C and R 3D are each independently C 1-18 represents a hydrocarbyl group, a 3- to 18-membered non-aromatic heterocyclic group, or a 5- to 18-membered aromatic heterocyclic group, 3A , R 3B , R 3C and R 3D The divalent carbon atom at any position excluding the terminal may be -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S- or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 3A , R 3B , R 3C and R 3D The hydrogen atoms contained in the formula (I) are, for example, (a) halogen atoms, (b) haloalkyl groups, (c) hydroxy groups, (d) thiol groups, (e) nitro groups, (f) cyano groups, (g) carboxy groups, (h) amino groups, (i) sulfo groups, (j) hydroxy groups or carboxy groups having a protecting group, or (k) C groups in which at least a part of the hydrogen atoms may be substituted with the above (a) to (j). 1-18 Hydrocarbyl group, C 1-18 Hydrocarbyloxy group, C 1-18 Hydrocarbyl carbonyl group, C 1-18 Hydrocarbylcarbonyloxy group, C 1-18 Hydrocarbyloxycarbonyl group, C 1-18 a hydrocarbyloxycarbonyloxy group, or C 1-18In a hydrocarbylthio group, the divalent carbon atom at any position except at the terminal of these substituents is -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S-, or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 3A , R 3B , R 3C and R 3D Any two of these are directly connected to each other by a single bond, or are divalent linking groups -O-, -S-, -C(=O)-, -S(=O)-, -S(=O) 2 -, -C(=O)O-, or C 1-3 They may be linked via an alkylene group to form a ring together with the nitrogen atom in formula (III).
[0035] R in formula (III) 3A , R 3B , R 3C and R 3D Each of the C groups independently has a substituent. 1-18 Preferably it is a hydrocarbyl group, C 1-12 Alkyl group, C 1-12 Alkenyl group, C 1-12 Alkynyl group, C 1-12 An alicyclic group is more preferred.
[0036] Specific examples of the organic quaternary ammonium cation include tetramethylammonium cation, tetraethylammonium cation, tetrapropylammonium cation, tetrabutylammonium cation, tetraheptylammonium cation, trimethylethylammonium cation, dimethyldiethylammonium cation, dimethylethylpropylammonium cation, methylethylpropylbutylammonium cation, trimethylphenylammonium cation, triethylhexylammonium cation, triethylcyclohexylammonium cation, and dodecyltrimethylammonium cation.
[0037] Polyacid salts are characterized by high thermal stability, oxidation resistance, high acid strength and oxidizing power, and reversible multi-electron redox ability, and examples of the synthesis and use of actinic ray-sensitive and radiation-sensitive polyoxometalates have been reported (e.g., JP-A-63-113452, JP-A-59-154089, JP-A-58-180400, etc.). However, because polyacid salts are salts of anionic polynuclear metal oxoclusters, they have poor solvent solubility, and it has been difficult to achieve a difference in solubility between areas exposed to actinic ray or radiation and areas not exposed to radiation. However, with the treatment liquid according to the present embodiment described below, it is possible to form a good pattern even when a polyacid salt is contained as the metal compound in the metal compound-containing film-forming composition.
[0038] In the metal compound-containing film-forming composition according to this embodiment, the content of the metal compound is not particularly limited and can be appropriately selected depending on the type of metal compound, the application, etc. The content of the metal compound in the metal compound-containing film-forming composition is preferably 0.5 to 20 mass %, more preferably 1 to 20 mass %, and even more preferably 1 to 10 mass %, based on 100 mass % of the metal compound-containing film-forming composition.
[0039] [1-1-2. Others] The metal compound-containing film-forming composition may contain organic solvents, inorganic fillers, quenchers, leveling agents, surfactants, and the like, as needed.
[0040] The organic solvent is not particularly limited as long as it can dissolve the metal compound and form a metal compound-containing film on the substrate. Examples of the organic solvent include halogenated hydrocarbons such as dichloromethane and 1,2-dichloroethane; alcohols such as methanol, ethanol, isopropanol, tert-butanol, 2-methyl-2-butanol, 4-methyl-2-pentanol, and diacetone alcohol; ethers such as propylene glycol monomethyl ether (PGME), diethyl ether, tetrahydrofuran, and 1,4-dioxane; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, 2-heptanone, and cyclohexanone; ethyl acetate, Examples of suitable organic solvents include esters such as n-butyl acetate, propylene glycol monomethyl ether acetate (PGMEA), ethyl lactate (EL), hydroxyisobutyrate methyl ester, and ethyl acetoacetate; lactones such as γ-butyrolactone (GBL) and ε-caprolactone; lactams such as N-methylpyrrolidone, nitriles such as acetonitrile and propionitrile; cyclic or acyclic carbonates such as dimethyl carbonate, ethylene carbonate, propylene carbonate, and diphenyl carbonate; polar aprotic solvents such as dimethyl sulfoxide and dimethylformamide; and water. These organic solvents may be used alone or in combination of two or more. The organic solvent contained in the metal compound-containing film-forming composition according to this embodiment is preferably propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), ethyl lactate (EL), γ-butyrolactone (GBL), methanol, water, or a combination thereof.
[0041] [1-2. Metal Compound-Containing Film Forming Step] The pattern forming method according to this embodiment includes a step of forming a metal compound-containing film on a substrate using a metal compound-containing film-forming composition.
[0042] <Substrate> The substrate used in this embodiment is not particularly limited, and a known and commonly used one can be used, for example, a substrate for electronic components, a substrate on which a predetermined wiring pattern is formed, etc. The material of the substrate is not particularly limited, and examples thereof include a silicon wafer, a substrate made of a metal such as copper, chromium, iron, or aluminum, and a substrate made of an inorganic material such as glass, titanium oxide, or silicon dioxide.
[0043] The size, shape, etc. of the substrate are not particularly limited, and the surface of the substrate may be smooth, curved, or uneven, or may be a thin plate-shaped substrate.
[0044] The surface of the substrate may be subjected to a surface treatment as necessary. In the case of a substrate having hydroxyl groups on its surface layer, the surface of the substrate is treated with a silane coupling agent capable of reacting with the hydroxyl groups, thereby changing the surface layer of the substrate from hydrophilic to hydrophobic, thereby improving the adhesion between the substrate and the metal compound-containing film. Examples of the silane coupling agent include hexamethyldisilazane (HMDS).
[0045] <Film formation method> The method for forming a metal compound-containing film on a substrate is not particularly limited, and any known or commonly used method can be used. As the film formation method, for example, a CVD method (chemical vapor deposition method) such as thermal CVD, plasma CVD, or photo CVD; a PVD method (physical vapor deposition method) such as vacuum deposition, plasma-assisted deposition, sputtering, or ion plating can be used as a dry method. Furthermore, for example, a coating method such as spin coating, bar coating, roll coating, flow coating, dip coating, spray coating, or screen printing can be used as a wet method.
[0046] As a method for forming a metal compound-containing film on a substrate using the metal compound-containing film-forming composition according to this embodiment, from the viewpoint of forming a uniform film thickness, etc., it is preferable to use a wet method such as spin coating or screen printing, and it is more preferable to use spin coating.
[0047] The method for drying the metal compound-containing film after it has been formed on the substrate is not particularly limited, and can be performed using, for example, a heating device such as a hot plate (post-applied bake (PAB)), a pressure reducing device, or the like. The baking conditions are not particularly limited, and can be set appropriately depending on the type and application of the metal compound-containing film. The baking temperature is preferably 100 to 300°C, more preferably 150 to 250°C, and even more preferably 170 to 230°C. The baking time is preferably 10 to 300 seconds, more preferably 20 to 180 seconds, and even more preferably 30 to 120 seconds.
[0048] The thickness of the metal compound-containing film after drying is not particularly limited, but is preferably 0.5 to 100 nm, more preferably 1 to 75 nm, and even more preferably 1 to 60 nm.
[0049] [1-3. Exposure Step of Metal Compound-Containing Film] The pattern formation method according to this embodiment includes a step of exposing the formed metal compound-containing film to light.
[0050] In the exposure step of the metal compound-containing film, an exposure device that can be used is an ArF exposure device, an electron beam lithography device, an EUV exposure device, etc. In the exposure step, exposure may be performed through a mask (mask pattern) on which a predetermined pattern is formed, or selective exposure may be performed by lithography using direct irradiation with an electron beam without using a mask pattern.
[0051] The wavelength used for exposure is not particularly limited, and examples thereof include ArF excimer laser (wavelength 193 nm), KrF excimer laser (248 nm), F 2 Radiation such as excimer laser (wavelength 157 nm), EUV (extreme ultraviolet), VUV (vacuum ultraviolet), EB (electron beam), X-ray, or soft X-ray may also be used.
[0052] The exposure dose on the metal compound-containing film is 1 to 100 mJ / cm in the case of an ArF excimer laser or a KrF excimer laser. 2 is preferably 20 to 60 mJ / cm 2In the case of extreme ultraviolet rays, the exposure dose is preferably 0.1 to 20 mJ / cm. 2 is preferably 3 to 15 mJ / cm 2 In the case of an electron beam, it is more preferable that the concentration is 3 μC / cm at 50 kV. 2 ~2mC / cm 2 It is preferable to expose with a dose of 10 μC / cm 2 ~1.5mC / cm 2 It is preferred to expose at a dose of 1000 ppm.
[0053] After the metal compound-containing film is exposed to light, it may be subjected to baking (post-exposure bake (PEB)). The baking conditions are not particularly limited and can be set appropriately depending on the type of metal compound-containing film, its intended use, and the like. The baking temperature is preferably 120 to 300°C, more preferably 150 to 250°C, and even more preferably 170 to 230°C, using a heating device such as a hot plate. The baking time is preferably 10 to 300 seconds, more preferably 20 to 180 seconds, and even more preferably 30 to 120 seconds.
[0054] [1-4. Treatment Step Using Treatment Liquid] The pattern formation method according to this embodiment includes a step of treating the exposed metal compound-containing film with a treatment liquid.
[0055] <Treatment Liquid> The treatment liquid according to this embodiment contains an organic solvent. The content of the organic solvent contained in the treatment liquid is not particularly limited and can be appropriately set depending on the type of organic solvent, the type of metal compound-containing film to be treated, and the like. The content of the organic solvent contained in the treatment liquid is preferably 25 to 100 mass %, more preferably 30 to 100 mass %, and even more preferably 30 to 90 mass %, relative to 100 mass % of the treatment liquid.
[0056] The organic solvent contains one or more first solvents that satisfy the following conditions (1) and (2): (1) ClogP≦0.7 (2) ΔH+ΔP≧16
[0057] (ClogP) Here, the ClogP value is a value obtained by calculating the common logarithm logP of the partition coefficient P between 1-octanol and water. Well-known and commonly used methods and software can be used to calculate the ClogP value. In this specification, the ClogP value calculated using DataWarrior V5.5.0 (www.openmolecules.org) is used.
[0058] The solvent having a ClogP value of 0.7 or less is not particularly limited, and examples thereof include dimethylformamide (DMF) (ClogP value=-0.45), dimethylacetamide (ClogP value=-0.0789), methanol (MeOH) (ClogP value=-0.36), ethanol (EtOH) (ClogP value=0.05), 3-methoxy-1-butanol (ClogP value=0.37), 1-methoxy-2-propanol (PE or PGME) (ClogP value=-0.09), propylene glycol monomethyl ether acetate (PGMEA) (ClogP value=0.40), acetylacetone (ClogP value=0.23), hydroxyacetone (ClogP value=-0.55), 4-hydroxy-2-butanone (ClogP value=-0.09), diisopropyl ether (DIET) (ClogP value=0.10), methyl ether (DMF) (ClogP value=-0.10), methyl ether (DIET) (ClogP value= ... Examples of suitable solvents include acetone alcohol (ClogP value = 0.65), methyl 2-hydroxyisobutyrate (ClogP value = -0.06), N-methyl-2-pyrrolidone (ClogP value = 0.09), ethyl lactate (EL) (ClogP value = -0.03), methyl methoxypropionate (ClogP value = 0.08), γ-butyrolactone (ClogP value = -0.02), isopropanol (ClogP value = 0.41), dimethyl sulfoxide (ClogP value = -1.28), diethylene glycol (ClogP value -0.97), ethylene glycol (ClogP value = -0.88), dipropylene glycol (ClogP value = -0.06), propylene glycol (ClogP value = -0.52), and γ-butyrolactone (ClogP value = -0.02). These solvents may be used alone or in combination of two or more.
[0059] (ΔH + ΔP) The Hansen solubility parameter divides the solubility of a substance into three components: a dispersion term ΔD, a polar term ΔP, and a hydrogen bonding term ΔH, and represents it in three-dimensional space. Here, the dispersion term ΔD indicates the effect of dispersion forces, the polar term ΔP indicates the effect of dipole-dipole forces, and the hydrogen bonding term ΔH indicates the effect of hydrogen bonds. The Hansen solubility parameter can be calculated using known and commonly used methods and software. In this specification, the estimated values of ΔH and ΔP calculated using Hansen Solubility Parameters in Practice (HSPiP) 5th edition 5.4.02 are used.
[0060] The value of ΔH + ΔP is 16 (MPa 1 / 2 ) or more, is not particularly limited, and examples thereof include DMF (ΔH+ΔP=25), MeOH (ΔH+ΔP=34.6), EtOH (ΔH+ΔP=26.5), t-butanol (t-BuOH) (ΔH+ΔP=20.2), 3-methoxy-1-butanol (ΔH+ΔP=18.6), 3-methoxy-3-methyl-1-butanol (ΔH+ΔP=16.8), PE or PGME (ΔH+ΔP=20), acetylacetone (ΔH+ΔP=17.8), hydroxyacetone (ΔH+ΔP=29.3), 4-hydroxy-2-butanone (ΔH+ΔP=25.8), diacetone alcohol (ΔH+ΔP=18.6), methyl 2-hydroxyisobutyrate (ΔH+ΔP=19.7), and ethylene glycol (ΔH+ΔP=40.9). Other solvents that may be used include dimethylacetamide (ΔH+ΔP=21.8), N-methyl-2-pyrrolidone (ΔH+ΔP=19.5), dimethyl sulfoxide (ΔH+ΔP=22.7), and γ-butyrolactone (ΔH+ΔP=23.3). These solvents may be used alone or in combination of two or more.
[0061] (First Solvent) The organic solvent contained in the treatment liquid according to this embodiment includes one or more first solvents that satisfy (1) ClogP≦0.7 and (2) ΔH+ΔP≧16. The content of the first solvent contained in the organic solvent is preferably 30% by mass or more, more preferably 30 to 90% by mass, and even more preferably 40 to 80% by mass, relative to 100% by mass of the organic solvent.
[0062] Examples of the first solvent that satisfies the above conditions (1) and (2) include, but are not limited to, DMF, MeOH, EtOH, isopropyl alcohol, n-butyl alcohol, sec-butyl alcohol, isobutyl alcohol, 3-methoxy-1-butanol, PE or PGME, acetylacetone, hydroxyacetone, 4-hydroxy-2-butanone, diacetone alcohol, methyl 2-hydroxyisobutyrate, ethyl lactate (EL), γ-butyrolactone, acetonitrile, dimethylacetamide, dimethyl sulfoxide, ethylene glycol, etc. These solvents may be used alone or in combination of two or more.
[0063] (Second Solvent) The organic solvent contained in the treatment liquid according to this embodiment may contain one or more second solvents different from the first solvent. The content of the second solvent contained in the organic solvent is not particularly limited, and from the viewpoint of selectively reducing the film in the unexposed areas, the second solvent is contained in an amount of preferably 1 to 70% by mass, more preferably 10 to 70% by mass, and even more preferably 20 to 60% by mass, relative to 100% by mass of the organic solvent.
[0064] The second solvent may be an alcohol solvent, an amide solvent, an ester solvent, an ether solvent, a ketone solvent, a hydrocarbon solvent, or the like, other than the organic solvent contained in the first solvent. Examples of alcohol solvents include alcohols such as tert-butyl alcohol, n-hexyl alcohol, n-heptyl alcohol, n-octanol, and 4-methyl-2-pentanol (MIBC); glycols such as triethylene glycol; and glycol ethers having a hydroxyl group such as propylene glycol monomethyl ether, diethylene glycol monomethyl ether, triethylene glycol monoethyl ether, methoxymethylbutanol, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, and propylene glycol monobutyl ether. Examples of amide solvents include N-methyl-2-pyrrolidone. Examples of ester-based solvents include butyl acetate, ethyl acetate, isopropyl acetate, amyl acetate, isoamyl acetate, butyl lactate, dibutyl carbonate, propylene glycol monomethyl ether acetate (PGMEA), ethylene glycol monoethyl ether acetate, ethylene glycol monopropyl ether acetate, ethylene glycol monobutyl ether acetate, diethylene glycol monomethyl ether acetate, diethylene glycol monopropyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, 2-methoxybutyl acetate, 3-methoxybutyl acetate, 4-methoxybutyl acetate, etc. Examples of ether-based solvents include propylene glycol dimethyl ether, propylene glycol diethyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, tetrahydrofuran, anisole, etc. Examples of ketone solvents include 1-hexanone, 2-hexanone, 1-heptanone, 2-heptanone, diisobutyl ketone, cyclohexanone, cycloheptanone, and methyl isobutyl ketone (MIBK).Examples of hydrocarbon solvents include butane, pentane, hexane, heptane, octane, nonane, decane, undecane, dodecane, etc. These solvents may be used alone or in combination of two or more.
[0065] The alcohol solvent used as the second solvent is preferably an alcohol solvent containing 3 or more carbon atoms, such as tert-butyl alcohol, n-hexyl alcohol, n-heptyl alcohol, octanol, 4-methyl-2-pentanol (MIBC), etc., and more preferably an alcohol solvent containing 3 to 12 carbon atoms. Furthermore, the ester solvent used as the second solvent is preferably an ester solvent containing 3 or less oxygen atoms, such as butyl acetate, butyl lactate, propylene glycol monomethyl ether acetate (PGMEA), ethylene glycol monoethyl ether acetate, ethylene glycol monopropyl ether acetate, 2-methoxybutyl acetate, 3-methoxybutyl acetate, 4-methoxybutyl acetate, etc. The ketone solvent used as the second solvent is preferably a ketone solvent that does not contain two or more oxygen atoms, such as 1-hexanone, 2-hexanone, 1-heptanone, 2-heptanone, diisobutyl ketone, cyclohexanone, cycloheptanone, methyl isobutyl ketone (MIBK), etc.
[0066] Furthermore, it is preferable to use, as the second solvent, one or more organic solvents that satisfy either (3) ClogP>0.7 and (4) ΔH+ΔP≦25, or (5) ClogP≧0.35 and (6) ΔH+ΔP<16.
[0067] Examples of the second solvent satisfying the above (3) and (4) or the above (5) and (6) include, but are not limited to, propylene glycol monomethyl ether acetate (PGMEA), ethyl acetate, butyl acetate, 3-methoxy-3-methyl-1-butanol, 4-methyl-2-pentanol (MIBC), methyl isobutyl ketone (MIBK), benzyl alcohol, t-butyl alcohol, octanol, hexane, decane, diethylene glycol monobutyl ether (BDG), etc. These solvents may be used alone or in combination of two or more.
[0068] That is, the second solvent is preferably one or more organic solvents different from the first solvent and selected from the group consisting of alcohol solvents, ester solvents, and ketone solvents, and next more preferably one or more solvents different from the first solvent and selected from the group consisting of alcohol solvents containing 3 or more carbon atoms, ester solvents containing 3 or less oxygen atoms, and ketone solvents containing no more than 2 oxygen atoms, and in addition (3) ClogP > 0.7, and (4) ΔH + ΔP ≦ 25, or (5) ClogP ≧ 0. 35, and (6) one or more solvents satisfying ΔH+ΔP<16, and particularly preferably one or more organic solvents selected from the group consisting of propylene glycol monomethyl ether acetate (PGMEA), ethyl acetate, butyl acetate, 3-methoxy-3-methyl-1-butanol, 4-methyl-2-pentanol (MIBC), methyl isobutyl ketone (MIBK), benzyl alcohol, t-butyl alcohol, octanol, hexane, decane, and diethylene glycol monobutyl ether (BDG).
[0069] The treatment liquid according to the present embodiment may further contain water. Although water itself is a poor solvent for the metal compound-containing film, by including water in the treatment liquid, the performance of the formed pattern can be improved compared to when only an organic solvent is used as the treatment liquid.
[0070] The water content in the treatment liquid is not particularly limited, and when the treatment liquid is taken as 100% by mass, the water content is preferably 1 to 75% by mass, more preferably 10 to 70% by mass, and even more preferably 20 to 60% by mass.
[0071] (Use of Treatment Solution) The treatment solution can be suitably used as a developer for developing the metal compound-containing film after the exposure step, and as a rinse solution for rinsing the developed metal compound-containing film. In particular, the treatment solution according to this embodiment has a difference in solubility between the exposed and unexposed parts of the metal compound-containing film, and can create a contrast between the exposed and unexposed parts. For this reason, the metal compound-containing film can be treated with an ArF excimer laser (wavelength 193 nm), a KrF excimer laser (248 nm), or an F 2 The treatment solution can be suitably used as a negative developer for developing a metal compound-containing film after exposure to an excimer laser (wavelength 157 nm), EUV (extreme ultraviolet), VUV (vacuum ultraviolet), EB (electron beam), X-ray, etc. In other words, the unexposed portions of the metal compound-containing film can be selectively dissolved and removed by the treatment solution to form a metal compound-containing film pattern.
[0072] <Treatment Step> The pattern formation method according to this embodiment includes a step of treating the exposed metal compound-containing film with a treatment liquid.
[0073] The method of developing the metal compound-containing film using the treatment liquid as the developer is not particularly limited, and can use known and commonly used methods.As the method of developing using the treatment liquid, for example, the method of immersing the substrate with the metal compound-containing film after exposure in the treatment liquid for a certain time (dipping method), the method of spraying the treatment liquid on the surface of the metal compound-containing film after exposure (spray method), the method of ejecting the treatment liquid from an ejection nozzle at a certain speed toward the surface of the metal compound-containing film after exposure on the substrate that rotates at a certain speed (dynamic dispensing method) etc.
[0074] In addition, the method for cleaning the developed metal compound-containing film pattern using the treatment liquid as a rinsing liquid is not particularly limited, and any known or commonly used method can be used. Examples of the method for rinsing using the treatment liquid include a method of immersing a substrate having a metal compound-containing film pattern in the treatment liquid for a certain period of time (dipping method), a method of spraying the treatment liquid onto the surface of the metal compound-containing film pattern (spray method), and a method of ejecting the treatment liquid from an ejection nozzle at a constant speed toward the surface of the metal compound-containing film pattern on a substrate rotating at a constant speed (spin coating method).
[0075] [2. Treatment Solution for Metal Compound-Containing Film] The treatment solution for metal compound-containing film according to this embodiment contains an organic solvent. The content of the organic solvent contained in the treatment solution for metal compound-containing film is not particularly limited and can be appropriately set depending on the type of organic solvent, the type of metal compound-containing film to be treated, and the like. The content of the organic solvent contained in the treatment solution for metal compound-containing film is preferably 25 to 100 mass %, more preferably 30 to 100 mass %, and even more preferably 30 to 90 mass %, relative to 100 mass % of the treatment solution for metal compound-containing film.
[0076] The treatment solution for a metal compound-containing film according to this embodiment is characterized in that it contains, in an organic solvent, one or more first solvents having ClogP≦0.7 and ΔH+ΔP≧16 in an amount of 30% by mass or more, when the organic solvent is taken as 100% by mass.
[0077] The organic solvent in the metal compound-containing film treatment solution according to another embodiment may further contain one or more second solvents different from the first solvent in an amount of 1 to 70% by mass relative to 100% by mass of the organic solvent. From the viewpoint of selectively reducing the film in the unexposed areas, the content of the second solvent contained in the organic solvent is preferably 1 to 70% by mass, more preferably 10 to 70% by mass, and even more preferably 20 to 60% by mass relative to 100% by mass of the organic solvent.
[0078] The second solvent is preferably one or more solvents different from the first solvent and selected from the group consisting of alcohol solvents, ester solvents, and ketone solvents, and more preferably one or more solvents different from the first solvent and selected from the group consisting of alcohol solvents containing 3 or more carbon atoms, ester solvents containing 3 or less oxygen atoms, and ketone solvents containing no more than 2 oxygen atoms, and in addition, (3) ClogP > 0.7, and (4) ΔH + ΔP ≦ 25, or (5) ClogP ≧ 0.35. and (6) ΔH+ΔP<16, and more preferably one or more solvents selected from the group consisting of propylene glycol monomethyl ether acetate (PGMEA), ethyl acetate, butyl acetate, 3-methoxy-3-methyl-1-butanol, 4-methyl-2-pentanol (MIBC), methyl isobutyl ketone (MIBK), benzyl alcohol, t-butyl alcohol, octanol, hexane, decane, and diethylene glycol monobutyl ether (BDG).
[0079] The metal compound-containing film treatment liquid according to another embodiment may contain water in addition to the organic solvent. The content of water in the metal compound-containing film treatment liquid is preferably 1 to 75 mass %, more preferably 10 to 70 mass %, and even more preferably 20 to 60 mass %, relative to 100 mass % of the metal compound-containing film treatment liquid.
[0080] The metal compound-containing film treatment solution according to this embodiment is capable of forming a good pattern even when the metal compound-containing film contains a polyoxometalate as the metal compound, and can be suitably used as a polyoxometalate-containing film treatment solution.
[0081] EXAMPLES The present invention will be specifically explained below by showing examples, but the present invention is not limited to these examples.
[0082] [1. Preparation of Test Metal Compound-Containing Film-Forming Composition F] Hexakis(bis(2-trifluoromethylphenyl)phenylsulfonium)metatungstate (metal compound M) as a metal compound, and dimethylformamide (DMF) and ethyl lactate (EL) as solvents were blended so that the contents of each component were in the amounts (unit: parts by mass) shown in Table 1, and the mixture was mixed with a stirrer to prepare a test metal compound-containing film-forming composition F.
[0083]
[0084] <Synthesis of Metal Compound M> Metal compound M was synthesized by the following method and used to prepare a test metal compound-containing film-forming composition F. 6.68 g of bis(2-trifluoromethylphenyl)phenylsulfonium chloride was dissolved in 99.36 g of pure water to obtain ammonium metatungstate (ammonium metatungstate hydrate ((NH 4 ) 6 [H 2 W 12 O 40 ]・xH 2 6.88 g of methyl methyl ketone (MgO) was added, and the reaction solution was stirred at room temperature for 30 minutes. The reaction solution was filtered, and the resulting powder was dried under reduced pressure at room temperature for 18 hours. The dried powder was dissolved in 100 g of dimethylformamide, and then 335 g of methanol was added. Crystallization at room temperature yielded metal compound M.
[0085] [2. Preparation of Test Film] <Film Formation Step> Test metal compound-containing film-forming composition F was applied using a spinner onto an 8-inch silicon substrate that had been treated with hexamethyldisilazane (HDMS), and the substrate was subjected to a post-applied bake (PAB) treatment on a hot plate at a temperature of 200°C for 60 seconds, followed by drying, to form a test metal compound-containing film with a film thickness of 50 nm. The average thickness of the formed metal compound-containing film was measured using a film thickness measuring device ("M-2000D" manufactured by J.A. Woollam Co.).
[0086] <Exposure Step> The test metal compound-containing film was exposed to light by open frame exposure using a KrF exposure device ("NSR-S203B" manufactured by NIKON Corporation, NA (numerical aperture) = 0.68, σ = 0.75) at an exposure dose of 50 mJ / cm2 After the exposure, a post-exposure bake (PEB) treatment was carried out at 180° C. for 60 seconds to prepare a test film.
[0087] [3. Investigation and Evaluation of Treatment Solutions (Single Solvent)] The test films were developed for 60 seconds at 23° C. using treatment solutions A-1 to A-24 listed in Table 2 below, and then rinsed for 15 seconds at 23° C. using 2-propanol. Thereafter, the change in film thickness between the exposed and unexposed areas was measured using a film thickness measuring device.
[0088] <Film reduction in unexposed areas> Focusing on the change in film thickness before and after development in the unexposed areas of the test film, the film reduction in unexposed areas (= ((film thickness before development - film thickness after development) / film thickness before development) x 100 (%)) was calculated, and the developability of each processing liquid was evaluated according to the following criteria. The results are shown in Table 2. A (very good): Film reduction in unexposed areas was 80% or more and 100% or less B (good): Film reduction in unexposed areas was 40% or more and less than 80% C (poor): Film reduction in unexposed areas was less than 40%
[0089]
[0090] From Table 2, it can be seen that when a solvent having a ClogP value of 0.7 or less and a ΔH+ΔP value of 16 or more was used as a treatment solution, as in treatment solutions A-1 to A-13, the evaluation of the film loss in the unexposed portion of the test film was judged as A or B, giving good results. On the other hand, when the solvent had a ClogP value of 0.7 or less but a ΔH+ΔP value of less than 16, as in treatment solution A-18, or when the solvent had a ΔH+ΔP value of 16 or more but a ClogP value of greater than 0.7, as in treatment solutions A-14, A-16, A-23, and A-24, the evaluation of the film loss in the unexposed portion of the test film gave a result of C. Furthermore, when the ClogP value of the solvent was greater than 0.7 and the ΔH+ΔP value was less than 16, as in the case of treatment solutions A-15, A-17, and A-19 to A-22, the evaluation of the film loss in the unexposed areas of the test film gave a result of C.
[0091] [4. Investigation and Evaluation of Treatment Solutions (Mixtures of First and Second Solvents)] The test films were developed for 60 seconds using treatment solutions B-1 to B-13 containing the first and second solvents listed in Table 3 below, and then rinsed for 15 seconds with 2-propanol. The film thickness change between the exposed and unexposed areas was then measured using a film thickness measuring device. Table 3 shows the (mass) ratios of solvents 1 and 2 in each treatment solution.
[0092] <Film reduction amount in unexposed portion> Focusing on the change in film thickness before and after development in the unexposed portion of the test film, the film reduction amount in the unexposed portion (= ((film thickness before development - film thickness after development) / film thickness before development) × 100 (%)) was calculated, and the developability of each processing liquid was evaluated according to the same criteria as above. The results are shown in Table 3.
[0093] <Evaluation of Selectivity> Focusing on the change in film thickness after development between the unexposed and exposed parts of the test film, the selectivity ratio (= film reduction amount in unexposed part / film reduction amount in exposed part) was calculated, and the selectivity of each treatment solution was evaluated according to the following criteria. The results are shown in Table 3. A (very good): Selectivity ratio of 20 or more B (good): Selectivity ratio of 10 or more but less than 20 C (poor): Selectivity ratio less than 10
[0094]
[0095] From Table 3, it can be seen that even in the case of treatment solutions B-1 to B-13, which are a mixture of a first solvent, PGME or MeOH, having a ClogP value of 0.7 or less and a ΔH + ΔP value of 16 or more, and a second solvent having a ClogP value of greater than 0.7 and / or a ΔH + ΔP value of less than 16, and which contain a predetermined amount of the first solvent, good results can be obtained in determining both the film loss amount and the selectivity of the unexposed portion of the test film. It can also be seen that, as in treatment solutions B-11 to B-13, by adjusting the ratio of the first solvent to the second solvent, the selectivity of the film loss amount between the unexposed portion and the exposed portion of the test film can be improved.
[0096] [5. Investigation and Evaluation of Treatment Solutions (Mixed Solvents of Organic Solvent and Water)] <Mixed Solvent of PGME and Water> The test film was developed for 60 seconds using treatment solutions C-1 to C-5, C-8, and C-10 containing an organic solvent (first solvent) and water, as shown in Table 4 below, and then rinsed for 15 seconds with 2-propanol. The film thickness change between the exposed and unexposed areas was then measured using a film thickness measuring device. Similarly, the test film was developed for 300 seconds at 23°C using treatment solutions C-6, C-7, C-9, and C-11, as shown in Table 4 below, and then rinsed for 15 seconds with 2-propanol at 23°C. The film thickness change between the exposed and unexposed areas was then measured using a film thickness measuring device. Table 4 shows the (mass) ratios of solvents 1 and 2 in each treatment solution. The film thickness loss and selectivity of the test film were evaluated according to the same criteria as above. The results are shown in Table 4.
[0097]
[0098] From Table 4, it can be seen that, as in the case of treatment solutions C-1 to C-7, when the ClogP value is 0.7 or less and the ΔH + ΔP value is 16 or more, in addition to PGME as the first solvent, and water is contained in an amount of 10 to 70 mass%, good results are obtained in the judgment of both the unexposed portion film loss amount and the selectivity ratio of the test membrane. On the other hand, as in the case of treatment solutions C-8 to C-11, when the water content in the treatment solution is 80% or more, the judgment result of the unexposed portion film loss amount of the test membrane was C. Furthermore, in treatment solution C-9, the judgment result of the selectivity ratio of the unexposed portion and the exposed portion of the test membrane was B, but in treatment solutions C-8, C-10 and C-11, the judgment result of the selectivity ratio was C.
[0099] <Mixed Solvents of Water and a First Solvent Other Than PGME> The test film was developed for 60 seconds using treatment solutions D-1 to D-11 containing the first solvent and water listed in Table 5 below, and then rinsed for 15 seconds with 2-propanol. The film thickness change in the exposed and unexposed areas was then measured using a film thickness measuring device. Table 5 shows the (mass) ratios of solvents 1 and 2 in each treatment solution. The film loss and selectivity of the unexposed areas of the test film were evaluated according to the same criteria as above. The results are shown in Table 5.
[0100]
[0101] From Table 5, it can be seen that when water is further contained in addition to the first solvent having a ClogP value of 0.7 or less and a ΔH + ΔP value of 16 or more, as in the case of treatment solutions D-1 to D-11, good results are obtained in both the evaluation of the film loss amount in the unexposed portion of the test film and the selectivity ratio. It can also be seen that, as in the case of treatment solutions D-1 to D-5, by adjusting the ratio of organic solvent (first solvent) to water, the selectivity ratio of the film loss amount in the unexposed portion and the exposed portion of the test film can be improved.
[0102] <Mixed Solvent of Organic Solvent (First Solvent and Second Solvent) and Water> The test film was developed for 60 seconds using treatment solutions E-1 to E-5 containing the organic solvents (first solvent and second solvent) and water listed in Table 6 below, and then rinsed for 15 seconds with 2-propanol. The film thickness change in the exposed and unexposed areas was then measured using a film thickness measuring device. Table 6 shows the (mass) ratios of solvents 1 to 3 in each treatment solution. The film loss and selectivity of the unexposed areas of the test film were evaluated according to the same criteria as above. The results are shown in Table 6.
[0103]
[0104] From Table 6, it can be seen that when a treatment solution containing 0 to 70% by mass of water is used, as in the case of treatment solutions E-1 to E-4, in addition to an organic solvent containing 70% by mass of a first solvent having a ClogP value of 0.7 or less and a ΔH + ΔP value of 16 or more and 30% by mass of another second solvent, good results are obtained in both the evaluation of the unexposed portion film loss and the selectivity of the test membrane. On the other hand, as in treatment solution E-5, when the water content in the treatment solution is 80%, the result of the evaluation of the unexposed portion film loss of the test membrane was C. In contrast, the evaluation of the selectivity of the unexposed portion and exposed portion of the test membrane of treatment solution E-5 gave a good result of A.
Claims
1. A pattern formation method comprising the steps of exposing a metal compound-containing film to light and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains an organic solvent, the organic solvent contains one or more first solvents having ClogP≦0.7 and ΔH+ΔP≧16, and the content of the first solvent is 30% by mass or more relative to 100% by mass of the organic solvent.
2. A pattern formation method comprising the steps of forming a metal compound-containing film using a metal compound-containing film-forming composition, exposing the metal compound-containing film to light, and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains an organic solvent, the organic solvent contains one or more first solvents having ClogP≦0.7 and ΔH+ΔP≧16, and the content of the first solvent is 30% by mass or more relative to 100% by mass of the organic solvent.
3. The pattern formation method according to claim 1, wherein the organic solvent further contains one or more second solvents different from the first solvent, and the content of the second solvent is 1 to 70 mass % relative to 100 mass % of the organic solvent.
4. The pattern formation method according to claim 3, wherein the second solvent is different from the first solvent and is one or more solvents selected from the group consisting of alcohol solvents containing three or more carbon atoms, ester solvents containing three or less oxygen atoms, and ketone solvents containing no more than two oxygen atoms.
5. The pattern formation method according to claim 3, wherein the second solvent is one or more solvents in which ClogP>0.7 and ΔH+ΔP≦25, or ClogP≧0.35 and ΔH+ΔP<16.
6. The pattern formation method according to claim 3, wherein the second solvent is one or more solvents selected from the group consisting of propylene glycol monomethyl ether acetate (PGMEA), ethyl acetate, butyl acetate, 3-methoxy-3-methyl-1-butanol, 4-methyl-2-pentanol (MIBC), methyl isobutyl ketone (MIBK), benzyl alcohol, t-butyl alcohol, octanol, hexane, decane, and diethylene glycol monobutyl ether (BDG).
7. The pattern forming method according to claim 1, wherein the treatment liquid further contains water.
8. The pattern formation method according to claim 7, wherein the content of the water is 1 to 75% by mass relative to 100% by mass of the treatment liquid.
9. The pattern forming method according to claim 1, wherein the metal compound-containing film is a metal compound-containing film containing a metal element of Groups 3 to 7.
10. The pattern forming method according to claim 1, wherein the metal compound is a polyoxometalate.
11. The pattern formation method according to claim 10, wherein the polyoxometalate is a polyoxomolybdate, a polyoxotungstate, a polyoxovanadate, a polyoxoniobate, or a polyoxotantalate.
12. The pattern forming method according to claim 10, wherein the polyoxometalate is an onium salt.
13. The pattern forming method according to claim 12, wherein the onium salt is an ammonium salt, a sulfonium salt, or an iodonium salt.
14. The pattern forming method according to claim 1, wherein the exposing step is a step of exposing with EUV or an electron beam.
15. A treatment solution for a metal compound-containing film, the treatment solution containing an organic solvent, the organic solvent containing one or more first solvents satisfying ClogP≦0.7 and ΔH+ΔP≧16, and the content of the first solvent is 30% by mass or more relative to 100% by mass of the organic solvent.
16. The treatment solution for a metal compound-containing film according to claim 15, wherein the organic solvent further contains one or more second solvents different from the first solvent, and the content of the second solvent is 1 to 70 mass % relative to 100 mass % of the organic solvent.
17. The treatment solution for a metal compound-containing film according to claim 16, wherein the second solvent is different from the first solvent and is one or more solvents selected from the group consisting of alcohol-based solvents containing three or more carbon atoms, ester-based solvents containing three or less oxygen atoms, and ketone-based solvents containing no more than two oxygen atoms.
18. The treatment solution for a metal compound-containing film according to claim 16, wherein the second solvent is one or more solvents in which ClogP>0.7 and ΔH+ΔP≦25, or ClogP≧0.35 and ΔH+ΔP<16.
19. The treatment solution for a metal compound-containing film according to claim 15, wherein the treatment solution further comprises water.
20. The metal compound-containing film treatment liquid according to any one of claims 15 to 19, which is a polyoxometalate-containing film treatment liquid.
Citation Information
Patent Citations
Gas flow measurement device and gas flow measurement system
JP2025113452A
Manufacturing method for solid-state battery
JP2025154089A
Display device, management apparatus, and display method
JP2025180400A
Tin dodecamers and radiation patternable coatings with strong EUV absorption
US11392028B2
Organometallic metal chalcogenide clusters and application to lithography
US20210026241A1
Cited By
Removal method, solution composition, and method for manufacturing semiconductor device
WO2026009862A1
